|
Previous COVID-19 Infection Is Protective Against Virus, but for How Long?
|
|
Evidence is mounting that recovered COVID-19 patients have significant immunity to the virus, although it remains unclear how long that lasts. Find out why authors of a new study believe that information is significant not just for those people but also for public policy and vaccine distribution prioritization.
|
|
|
BPH Medications Linked to Increased Heart-Failure Risk in Men
|
|
|
Benign prostatic hyperplasia (BPH) is a common condition among older men, and many patients are treated with alpha-blockers and 5-alpha reductase inhibitors. A new study suggests that those therapies, especially alpha-blockers, can increase men’s probability of developing for heart failure, although the absolute risks remain low. Here are more details.
|
|
Loss of Smell, Taste Can Linger for Months in Recovered COVID-19 Patients
|
|
|
Pharmacists often are queried on when recovered COVID-19 patients will get their smell and taste back. Results from a recent Canadian study might be disappointing for some questioners. Surveys of healthcare workers who lost those senses during infection suggests the problem can linger for 5 months or longer. Here is more information.
|
|
|
Amoxicillin-Clavulanate Might Be Safer Option for
Uncomplicated Diverticulitis
|
|
Uncomplicated diverticulitis often is treated in an outpatient setting and managed with antibiotics. As pharmacists know, patients most commonly are prescribed a combination of metronidazole and a fluoroquinolone. Find out why authors of a new study suggest that isn’t the best option and why an amoxicillin-clavulanate combination might be safer.
|
|
